Bluejay Diagnostics, Inc. Payments of Debt Issuance Costs
Bluejay Diagnostics, Inc. (BJDX) reported Payments of Debt Issuance Costs of $562.84 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2022-11-09
- Bluejay Diagnostics, Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $169.39K.
- Bluejay Diagnostics, Inc. payments of debt issuance costs for the quarter ending 2021-09-30 was $305.90K.
- Bluejay Diagnostics, Inc. payments of debt issuance costs for the quarter ending 2021-06-30 was $74.53K.
- Bluejay Diagnostics, Inc. payments of debt issuance costs for the quarter ending 2021-03-31 was $13.03K.
- Bluejay Diagnostics, Inc. payments of debt issuance costs for fiscal 2021 was $562.84K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 9 month as first filed | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $169.39K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $475.29K derived: sum of 2 quarters · filed 2022-11-09 | $549.82K derived: sum of 3 quarters · filed 2022-11-09 | $562.84K 10-K · filed 2022-03-10 | |
| 2021-09-30 | $305.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $380.43K derived: sum of 2 quarters · filed 2022-11-09 | $393.45K 10-Q · filed 2022-11-09 | $562.84K 10-Q · filed 2021-12-16 | |
| 2021-06-30 | $74.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $87.55K 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $13.03K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |